PUBLIC HEALTH ALERT: WHO ISSUES YELLOW FEVER WARNING ACROSS WEST AFRICA AS NIGERIA RECORDS CASES

ABUJA, NIGERIA — The World Health Organization (WHO) has issued a regional public health alert across West Africa after confirming 67 laboratory-confirmed cases of Yellow Fever and 18 deaths across nine African nations.

​According to WHO epidemiological data covering the reporting period between January 1 and October 12, 2026, Nigeria recorded four confirmed cases and one fatality.

​1. Regional Breakdown & Affected Countries

​The disease outbreak has affected nine countries in the WHO African Region, with the heaviest burden concentrated along West African border corridors:

  • ​Côte d’Ivoire: 30 confirmed cases, 10 deaths
  • ​Burkina Faso: 15 confirmed cases, 3 deaths
  • ​Cameroon: 9 confirmed cases, 1 death
  • ​Ghana: 4 confirmed cases, 3 deaths
  • ​Nigeria: 4 confirmed cases, 1 death
  • ​Central African Republic (CAR): 2 confirmed cases, 0 deaths
  • ​Guinea, Liberia & Togo: 1 confirmed case each

​WHO evaluated the regional public health risk as moderate due to frequent cross-border movements, agricultural and mining activities near forest edges, and gaps in routine immunization coverage. However, global public health risk remains low.

​2. Vulnerability Factors & Transmission Risks

​Public health experts highlight several factors accelerating the spread of the mosquito-borne virus:

  • ​High-Risk Populations: Unvaccinated individuals, forest-edge agricultural workers, miners, and cross-border traders face the highest exposure risks.
  • ​Vector Transmission: The primary vector, Aedes mosquitoes, breeds in both urban containers and rural/forest environments, facilitating transmission between wild and human populations.
  • ​Diagnostic Delay: Regional sample referrals to accredited reference laboratories (such as the Institut Pasteur in Dakar) can delay rapid case confirmations in remote areas.

​3. Prevention, Vaccination & Preventive Measures

​Health authorities emphasize that Yellow Fever is preventable through active immunization:

  • ​Single-Dose Lifetime Protection: A single dose of the yellow fever vaccine provides lifelong immunity without requiring a booster shot.
  • ​Supportive Care: There is no specific antiviral treatment for Yellow Fever; medical management relies on supportive clinical care.
  • ​Travel Advisory: WHO advises all international travelers aged 9 months and older visiting at-risk regions to obtain a valid Yellow Fever vaccination certificate prior to travel.

​Regional Status Overview


CountryConfirmed CasesConfirmed DeathsPrimary Risk Profile
Côte d’Ivoire3010Cross-border agricultural corridors
Burkina Faso153Savanna border zones
Cameroon91Forest-edge populations
Ghana43Upper West district activity
Nigeria41

Nofakenews

Comments